Dropping the bomb
Article Abstract:
Issues concerning the nuclear attack plans harbored by the United States against Russia and by Russia against the United States are discussed. Particular attention is given to the type of persuasion and leadership needed to diminish military arsenal.
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
A plan under attack; did we start the war with enough force?
Article Abstract:
Military tactics and policies used during the war in Iraq are discussed. Equipment used by American and British troops is also described.
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Ground zero
Article Abstract:
U.S. intelligence seeks to correct its monitoring procedures after India's tested nuclear devices with three simultaneous 30-kiloton explosions which occurred without CIA knowledge. Economic pressure had been applied by the U.S. government, but Prime Minister Atal Bihari Vajpayee defied warnings.
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Ontario and Quebec unite to face PM; Harris says he won't sign health-care deal with Ottawa unless Bouchard approves
- Abstracts: One court battle between Miller and Anheuser-Busch is called off, but their war is far from over. Supreme Court's ruling in a tobacco case is hailed as a victory for commercial freedom of speech
- Abstracts: Defending a merger; Hewlett-Packard and Compaq react to critics. Executive bonuses included in the Hewlett-Compaq deal
- Abstracts: Soaring dollar reverses auto tide: Dealers warned not to resell US cars. Ford dealers' ire rose last year: poll
- Abstracts: At Vioxx Trial, a Discrepancy Appears to Undercut Merck's Defense. Struggling dot-com company gets opportunity for a second act